Norwegian salmon farming is going to crush it this next year. Underinvestment (because of confused investors) and increased demand are set to drive up the value of mass producer salmon facilities in the 2020s. The gmo salmon farming companies in Norway are outperforming as commodity plays, while organic salmon farming and aquaculture biotech appear to be bouncing off of the lows set by the overall market (probably because they correlate more so with biotech and XBI).